The Abell Foundation announced Tuesday that it has invested $250,000 in Vasoptic Medical Inc., a Baltimore-based firm that’s developing a portable retinal imager to make it easier to monitor diabetes and diseases of the eye.
Vasoptic moved into Baltimore from Columbia in August after a $250,000 investment last year from Abell, which makes targeted venture-capital investments in firms to foster technology and research in the city. The foundation’s ultimate goal is to create jobs in Baltimore.
"Expanding our investment in Vasoptic Medical Inc. is a win-win for Baltimore," the Abell Foundation board said in a statement. "Vasoptic is growing Baltimore's innovative tech industry and is poised to improve access to affordable healthcare for low-income populations."
For full story click here.